SARAH H SEE

Allopathic & Osteopathic Physicians|Internal Medicine FRANKLIN, TN NPI 1245440171

General Payments — all program years on this page

$1,659.35

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 79
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $437.46 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $437.4622

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $48.153
2021 $22.801
2022 $504.8420
2023 $646.1033
2024 $437.4622

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097382281 Novo Nordisk Inc $21.96 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097396976 Novo Nordisk Inc $21.95 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097823530 Novo Nordisk Inc $21.62 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105209230 AstraZeneca Pharmaceuticals LP $14.59 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106051036 ABBVIE INC. $23.36 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106051038 ABBVIE INC. $22.46 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106051040 ABBVIE INC. $16.30 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116100306 Amgen Inc. $20.08 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116365117 GlaxoSmithKline, LLC. $20.78 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117679243 Amgen Inc. $20.74 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117679245 Amgen Inc. $15.64 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117931463 Boehringer Ingelheim Pharmaceuticals, Inc. $16.28 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117931465 Boehringer Ingelheim Pharmaceuticals, Inc. $16.47 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117931467 Boehringer Ingelheim Pharmaceuticals, Inc. $20.48 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118978348 Otsuka America Pharmaceutical, Inc. $29.47 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124919395 Abbott Laboratories $16.49 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124919397 Abbott Laboratories $18.99 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124919399 Abbott Laboratories $20.23 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124919401 Abbott Laboratories $19.24 07/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135392301 Lilly USA, LLC $19.30 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139201360 Amneal Pharmaceuticals LLC $16.83 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139359233 Astellas Pharma US Inc $24.20 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.